AQbD Symposium 2023
Enhancing the Quality of Your Analytical Procedures

Analytical Quality by Design (AQbD) is a science and risk-based approach to analytical procedure development that “starts with the end in mind”.​

Embraced by industry, regulators and academia, the application of the AQbD principles aims to improve the quality of analytical procedures by using enhanced approaches to development, validation and performance monitoring.​

Join us on November 28th and 29th to hear from subject matter experts on recent development with ICH quality guidelines, implementation in the industry, and chromatography technologies that mitigate risk in the pharma QC laboratory.​

Each session will feature a panel of 3 forward thinking leaders on the topic who will present their recent work and participate in a round table discussion. 

Day 1: ICH Q2(R2)/Q14: Enhanced Approach to Analytical Procedures Development and Validation

Analytical Quality by Design (AQbD) is an enhanced approach to analytical method development that not only reduces risks and produces robust methods across your organization but is also becoming the preferred language of regulators when filing applications for both small and large molecules, synthetic or biological drugs. ​

Using the so-called enhanced approach can significantly reduce the time-to-market, which is crucial in recent times when new drugs are developed on accelerated timelines. ​

Join us on Tuesday, November 28th for an update on the ICH Q14 and Q2(R2) guidelines, and the impact for the industry.​

Followed by a live panel discussion with all the speakers. So have your questions ready!